Private Equity and Venture Capital Legal Advisory
We guide funds and startups through the complete investment lifecycle, from Series A fundraising to strategic exits, with a focus on practical deal architecture that protects your growth.
We advised health-tech startup Zeno Health on its $25 million Series C funding round led by STIC Investments. This transaction demonstrates our ability to guide growth-stage companies in securing capital for market expansion and technological enhancement.
We advised electric vehicle charging startup Exponent Energy on its $26.4 million Series B funding round. Our role involved facilitating the investment to help the company scale its charging network and expand into new electric vehicle segments like intercity e-buses.
We advised UAE-based CE-Invests on its Series C investment in Flipspaces, a tech-first interior design company. This deal is an example of our work in facilitating cross-border investments into Indian technology companies that are leveraging AI for global expansion.
We advised MedGenome, a leading genomic diagnostics company, on its Series E fundraise of approximately USD 47.5 million. This transaction supports the company's mission to broaden access to affordable, genetics-based diagnostics across emerging markets.
We advised Arkam Ventures and Fundamentum Partnership on their investment in TransBnk as part of its Series B fundraise. This deal supports the fintech platform's plans for technological enhancement and geographical expansion into Southeast Asia and the Middle East.
We advised construction materials firm Infra.Market on its $121 million pre-IPO fundraise. This transaction, involving prominent investors like Tiger Global and Nikhil Kamath, showcases our experience in guiding companies through significant late-stage funding rounds.
We advised Whiteboard Capital on its stake sale in wealth management platform Dezerv. This transaction was part of a cumulative Rs. 265 crore primary and secondary fundraise, highlighting our role in facilitating strategic exits for early-stage investors.
We advised tech product ODM iDO Devices on its fundraise from Blume Ventures and Merak Ventures. This investment supports the company's goal of establishing an integrated design and product delivery ecosystem in India for global electronics clients.
We advised Avaana Capital, a climate-tech VC fund, on its Series A investment in food upcycling startup Wastelink. This deal reflects our expertise in the growing climate-tech sector, supporting companies that create sustainable and resilient supply chains.
We advised Jungle Ventures on its US$ 18 million investment in wealth advisory firm Waterfield Advisors. Our role included comprehensive transaction advisory and due diligence, facilitating the deployment of capital for technology infrastructure and market expansion.
About Private Equity & Venture Capital Investments
We do not just draft Share Subscription Agreements; we focus on the specific architecture of your transaction. Whether you are navigating a Series A fundraise or a complex secondary stake sale, we implement governance frameworks like Section 166 clauses early on. This ensures your board and leadership are protected from personal liability while maintaining the speed required to close the deal.
Investment transactions require more than standard paperwork. A deal often fails not because of the legal theory, but because of friction in the closing mechanics or unclear commercial terms. Our approach is to identify these bottlenecks before they stall the process.
What We Bring to Your Deal
- Precision Structuring: We handle the nitty-gritty of anti-dilution, liquidation preferences, and ROFO/ROFR rights. We ensure your Articles and Memorandum of Association actually reflect the deal you signed, not just a template.
- Condition Precedent (CP) Management: The most common reason deals drag is poor CP management. We track and satisfy these conditions proactively to ensure funds transfer happens on schedule.
- Board & Director Protection: In the current regulatory environment, we prioritize implementing governance frameworks that shield founders and directors. We treat Section 166 duties as a critical risk factor, not an afterthought.
- Risk Quantification: For buy-side mandates, we cut through the due diligence noise. We categorize risks into fundamental warranties versus general indemnities so you know exactly what is worth negotiating and what is standard market practice.
We have supported high-growth companies across diverse sectors, from health-tech players like Zeno Health and MedGenome to EV infrastructure startups like Exponent Energy. Our goal is to provide a 'closing bible' that is watertight, compliant, and ready for your next round of growth.
Krishnava Dutt
I am Krishnava Dutt. At Argus Partners, we do not act like a traditional law firm that just points out risks. We look at the commercial endgame, helping founders and investors move past the friction points that stall transactions.
Looking for specific legal guidance?
Search for our practice areas or specific types of legal assistance below.
More from Corporate, M&A & Private Equity by Krishnava Dutt